✦ LIBER ✦

Cardiac transplantation and other therapeutic options in the treatment of end-stage heart disease

✍ Scribed by Robert Dabol; Niloo M. Edwards

Publisher: Springer
Year: 2000
Tongue: English
Weight: 76 KB
Volume: 26
Category: Article
ISSN: 0098-8243
DOI: 10.1007/s12019-000-0020-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular disease in end-stage rena

Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients

✍ Lisa M. Miller; Manish M. Sood; Amy R. Sood; Martina Reslerova; Paul Komenda; Cl 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 202 KB

The effect of liver transplantation on a

The effect of liver transplantation on autonomic dysfunction in patients with end-stage liver disease

✍ Elizabeth J. Carey; Manjushree Gautam; Timothy Ingall; David D. Douglas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Autonomic dysfunction is a recognized complication of end-stage liver disease (ESLD), but there is little information on how liver transplantation (LT) affects this problem. We sought to prospectively evaluate autonomic function in patients with ESLD before and after LT. Autonomic reflex screen (ARS

Survival after liver transplantation for

Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre–model for end-stage liver disease eras and the independent impact of hepatitis C virus

✍ Paul J. Thuluvath; Anurag Maheshwari; Nimisha P. Thuluvath; Geoffrey C. Nguyen; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo

Therapeutic angiogenesis: The combinatio

Therapeutic angiogenesis: The combination point of Chinese and western medicine in prevention and treatment of ischemic heart disease

✍ Zong-gui Wu 📂 Article 📅 2009 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 273 KB

A systematic review of the performance o

A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation

✍ Evangelos Cholongitas; Laura Marelli; Vibhakorn Shusang; Marco Senzolo; Keith Ro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

The Model for End-Stage Liver Disease (MELD) score is now used for allocation in liver transplantation (LT) waiting lists, replacing the Child-Turcotte-Pugh (CTP) score. However, there is debate as whether it is superior to CTP score to predict mortality in patients with cirrhosis on the LT waiting

Biliary complications following liver tr

Biliary complications following liver transplantation in the model for end-stage liver disease era: Effect of donor, recipient, and technical factors

✍ Theodore H. Welling; David G. Heidt; Michael J. Englesbe; John C. Magee; Randall 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Biliary complications remain a significant problem following liver transplantation in the Model for End-Stage Liver Disease (MELD) era. We hypothesized that donor, recipient, and technical variables may differentially affect anastomotic biliary complications in MELD era liver transplants. We reviewe